G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptid
Kurzübersicht für G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptid (ABIN939601)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- IWQRGKEEEG VYGFLIEDIR KEVNRASKLK CCVCKKNGAS IGCVAPRCKR
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA1333 antibody,
Alternative Names: KIAA1333 control peptide, KIAA1333 antibody Blocking Peptide, Anti-KIAA1333 Blocking Peptide, Kiaa1333 Blocking Peptide, FLJ20333 Blocking Peptide, G2E3 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
-
Hintergrund
- KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.
-
Molekulargewicht
- 80 kDa
Target
-